Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Glioma × mirdametinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1 Glioma 1 Glioblastoma 1

Interventions

Temozolomide 4 Blood Specimen Collection 2 vorasidenib 1 trametinib 1 tovorafenib 1 posaconazole 1 perillyl alcohol 1 pembrolizumab 1 niraparib 1 mirdametinib 1 gallium maltolate 1 dabrafenib 1 Urination 1 Transurethral Resection of Bladder 1 Standard of Care 1 Spinal Puncture 1 Specimen Handling 1 Radiotherapy 1 Radiation 1 Positron Emission Tomography Computed Tomography 1 Physical Therapy Modalities 1 Nivolumab 1 Microscopy 1 Mental Status and Dementia Tests 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Lomustine 1 Ketoconazole 1 Histocompatibility Testing 1 Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07521657 2026-04-13

NF118

University of Alabama at Birmingham

Phase 2 Not yet recruiting

Glioblastoma, Glioma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡